Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China

International Journal of Environmental Research and Public Health

Volumn 8, Issue 6, 2011, Pages 1991-2008

  Gao, Jianwei ^a,b   Yu, Jiangping ^a   Yang, Linsheng ^a  

^a INSTITUTE OF GEOGRAPHIC SCIENCES AND NATURAL RESOURCES RESEARCH   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Arsenic (AS); China; Coal arsenic poisoning (CAP); Methylation capability; Skin lesions; Urinary metabolites

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; CACODYLIC ACID; COAL; CREATININE; METHANEARSONIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CHINA; CONCENTRATION (PARAMETERS); CREATININE URINE LEVEL; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LONG TERM EXPOSURE; MALE; MASS SPECTROMETER; METHYLATION; SEX RATIO; SKIN DEFECT; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 79959829018     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8061991     Document Type: Article

References (53)

1. Lindberg, A.L.; Rahman, M.; Persson, L.A.; Vahter, M.; The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol. Appl. Pharmacol. 2008, 230, 9-16.
2. Ahsan, H.; Chen, Y.; Kibriya, M.G.; Slavkovich, V.; Parvez, F.; Jasmine, F.; Gamble, M.V.; Graziano, J.H.; Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1270-1278.
3. Hsueh, Y.M.; Huang, Y.L.; Huang, C.C.; Wu, W.L.; Chen, H.M.; Yang, M.H.; Lue, L.C.; Chen, C.J.; Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health Part A 1998, 54, 431-444.
4. Walton, F.S.; Harmon, A.W.; Paul, D.S.; Drobna, Z.; Patel, Y.M.; Styblo, M.; Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: Possible mechanism of arsenic-induced diabetes. Toxicol. Appl. Pharmacol. 2004, 198, 424-433.
5. Mushak, P.; Crocetti, A.F.; Risk and revisionism in arsenic cancer risk assessment. Environ. Health Perspect. 1995, 103, 684-689.
6. Vahter, M.; Concha, G.; Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 2001, 89, 1-5.
7. Petrick, J.S.; Ayala-Fierro, F.; Cullen, W.R.; Carter, D.E.; Vasken Aposhian, H.; Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163, 203-207.
8. Mandal, B.K.; Ogra, Y.; Suzuki, K.T.; Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 2001, 14, 371-378.
9. Hopenhayn-Rich, C.; Biggs, M.L.; Kalman, D.A.; Moore, L.E.; Smith, A.H.; Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 1996, 104, 1200-1207.
10. Meza, M.M.; Kopplin, M.J.; Burgess, J.L.; Gandolfi, A.J.; Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ. Res. 2004, 96, 119-126.
11. Del Razo, L.M.; Garcia-Vargas, G.G.; Vargas, H.; Albores, A.; Gonsebatt, M.E.; Montero, R.; Ostrosky-Wegman, P.; Kelsh, M.; Cebrian, M.E.; Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol. 1997, 71, 211-217.
12. Sun, G.; Xu, Y.; Li, X.; Jin, Y.; Li, B.; Sun, X.; Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ. Health Perspect. 2007, 115, 648-652.
13. Li, Y.; Relation between arsenic in environment and coal burning-born endemic arsenism in the south of Shaanxi province. China. J. Endemiol. 2004, 23, 562-565 (in Chinese).
14. Chen, P.; Tang, X.Y.; Arsenic in coal of China. Coal Geol. Chin. 2002, 14, 18-24 (in Chinese).
15. Yudovich, Y.E.; Arsenic in coal: A review. Int. J. Coal Geol. 2005, 61, 141-196.
16. Ministry of Health. Hygienic Standards for the Design of Industrial Enterprises, TJ 36-1979; Ministry of Health of the People's Republic of China: Beijing, China 1979.
17. Ministry of Health. Maximum Levels of Contaminants in Foods, GB 2762-2005; Ministry of Health of the People's Republic of China: Beijing, China, 2005.
18. Ministry of Health. Standards for Drin king Water Quality, GB 5749-2006; Ministry of Health of the People's Republic of China: Beijing, China, 2006.
19. Bai, G.L.; Liu, X.L.; Fan, Z.X. Li, X.Q.; Epldemiologic survey on coal-burning endemic arsenism in Shaanxi province. Chin. J. Endemiol. 2006, 25, 57-60 (in Chinese).
20. Tang, L.; The Transport and Transformation of Airborne Arsenic from Burning Stone-Like Coal in Shaanxi. Master dissertation, China Capital Normal University: Beijing, China. 2009 (in Chinese).
21. Ministry of Health. Stnadards of Diagnosis for Endemic Arsenism, WS/T 211-2001; Ministry of Health of the People's Republic of China: Beijing, China, 2001.
22. World Medical Association Declaration Of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. Available online: http://www.wma.net/en/30publications/10policies/b3/17c.pdf (accessed on 30 May 2011).
23. Cornelis, R.; Heinzow, B.; Herber, R.F.; Christensen, J.M.; Poulsen, O.M.; Sabbioni, E.; Templeton, D.M.; Thomassen, Y.; Vahter, M.; Vesterberg, O.; Sample collection guidelines for trace elements in blood and urine. J. Trace Elem. Med. Biol. 1996, 10, 103-127.
24. Chen, L.W.; Lu, X.; Le, X.C.; Complementary chromatography separation combined with hydride generation-inductively coupled plasma mass spectrometry for arsenic speciation in human urine. Anal. Chim. Acta 2010, 675, 71-75.
25. Xie, R.; Johnson, W.; Spayd, S.; Hall, G.S.; Buckley, B.; Arsenic speciation analysis of human urine using ion exchange chromatography coupled to inductively coupled plasma mass spectrometry. Anal. Chim. Acta 2006, 578, 186-194.
26. Lin, T.H.; Huang, Y.L.; Chemical speciation of arsenic in urine of patients with blackfoot disease. Biol. Trace Elem. Res. 1995, 48, 251-261.
27. Vahter, M.; Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999, 82, 69-88.
28. Vahter, M.; Concha, G.; Nermell, B.; Nilsson, R.; Dulout, F.; Natarajan, A.T.; A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 1995, 293, 455-462.
29. Chiou, H.Y.; Hsueh, Y.M.; Hsieh, L.L.; Hsu, L.I.; Hsu, Y.H.; Hsieh, F.I.; Wei, M.L.; Chen, H.C.; Yang, H.T.; Leu, L.C, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat. Res. 1997, 386, 197-207.
30. Lindberg, A.L.; Ekstrom, E.C.; Nermell, B.; Rahman, M.; Lonnerdal, B.; Persson, L.A.; Vahter, M.; Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ. Res. 2008, 106, 110-120.
31. Vahter, M.; Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 2000, 112-113, 209-217.
32. Choi, B.S.; Choi, S.J.; Kim, D.W.; Huang, M.; Kim, N.Y.; Park, K.S.; Kim, C.Y.; Lee, H.M.; Yum, Y.N.; Han, E.S.; et al. Effects of repeated seafood consumption on urinary excretion of arsenic species by volunteers. Arch. Environ. Contam. Toxicol. 2010, 58, 222-229.
33. Hsueh, Y.M.; Chiou, H.Y.; Huang, Y.L.; Wu, W.L.; Huang, C.C.; Yang, M.H.; Lue, L.C.; Chen, G.S.; Chen, C.J.; Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol. Biomarkers Prev. 1997, 6, 589-596.
34. Vahter, M.; Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182, 211-217.
35. Thomas, D.J.; Styblo, M.; Lin, S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 2001, 176, 127-144.
36. Styblo, M.; Drobna, Z.; Jaspers, I.; Lin, S.; Thomas, D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Health Perspect. 2002, 110, 767-771.
37. Tseng, C.H. Arsenic methylation, urinary arsenic metabolites and human diseases: Current perspective. J. Environ. Sci. Health, Part C: Environ. Carcinog. Ecotoxicol. Rev. 2007, 25, 1-22.
38. Gong, Z. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 2001, 16, 1409-1413.
39. Chung, C.J.; Huang, C.J.; Pu, Y.S.; Su, C.T.; Huang, Y.K.; Chen, Y.T.; Hsueh, Y.M. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol. Appl. Pharmacol. 2008, 226, 14-21.
40. Gamble, M.V.; Liu, X.; Ahsan, H.; Pilsner, R.; Ilievski, V.; Slavkovich, V.; Parvez, F.; Levy, D.; Factor-Litvak, P.; Graziano, J.H. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ. Health Perspect. 2005, 113, 1683-1688.
41. Shraim, A.; Cui, X.; Li, S.; Ng, J.C.; Wang, J.; Jin, Y.; Liu, Y.; Guo, L.; Li, D.; Wang, S.; et al. Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coal-burning in Guizhou, PR China. Toxicol. Lett. 2003, 137, 35-48.
42. Zeisel, S.H. Betaine supplementation and blood lipids: Fact or artifact? Nutr. Rev. 2006, 64, 77-79.
43. Chiuve, S.E.; Giovannucci, E.L.; Hankinson, S.E.; Zeisel, S.H.; Dougherty, L.W.; Willett, W.C.; Rimm, E.B. The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am. J. Clin. Nutr. 2007, 86, 1073-1081.
44. Chen, Y.C.; Su, H.J.; Guo, Y.L.; Hsueh, Y.M.; Smith, T.J.; Ryan, L.M.; Lee, M.S.; Christiani, D.C. Arsenic methylation and bladder cancer risk in Taiwan. Canc. Causes Contr. 2003, 14, 303-310.
45. Lindberg, A.L.; Sohel, N.; Rahman, M.; Persson, L.A.; Vahter, M. Impact of smoking and chewing tobacco on arsenic-induced skin lesions. Environ. Health Perspect. 2010, 118, 533-538.
46. Vahter, M.; Akesson, A.; Liden, C.; Ceccatelli, S.; Berglund, M. Gender differences in the disposition and toxicity of metals. Environ. Res. 2007, 104, 85-95.
47. Chen, C.J.; Hsu, L.I.; Wang, C.H.; Shih, W.L.; Hsu, Y.H.; Tseng, M.P.; Lin, Y.C.; Chou, W.L.; Chen, C.Y.; Lee, C.Y.; et al. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol. Appl. Pharmacol. 2005, 206, 198-206.
48. Guha Mazumder, D.N.; Haque, R.; Ghosh, N.; De, B.K.; Santra, A.; Chakraborty, D.; Smith, A.H. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol. 1998, 27, 871-877.
49. Watanabe, C.; Inaoka, T.; Kadono, T.; Nagano, M.; Nakamura, S.; Ushijima, K.; Murayama, N.; Miyazaki, K.; Ohtsuka, R. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: Analyses based on urinary arsenic. Environ. Health Perspect. 2001, 109, 1265-1270.
50. Huang, Y.K.; Huang, Y.L.; Hsueh, Y.M.; Yang, M.H.; Wu, M.M.; Chen, S.Y.; Hsu, L.I.; Chen, C.J. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: A twelve-year follow-up study. Canc. Causes Contr. 2008, 19, 829-839.
51. Tseng, C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharmacol. 2009, 235, 338-350.
52. Cascio, C.; Raab, A.; Jenkins, R.O.; Feldmann, J.; Meharg, A.A.; Haris, P.I. The impact of a rice based diet on urinary arsenic. J. Environ. Monit. 2011, 13, 257-265.
53. Navas-Acien, A.; Umans, J.G.; Howard, B.V.; Goessler, W.; Francesconi, K.A.; Crainiceanu, C.M.; Silbergeld, E.K.; Guallar, E. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: The Strong Heart Study. Environ. Health Perspect. 2009, 117, 1428-1433.